hotspot -WSS

hotspot

author：Wikipedia 2025-09-30 16:29:08 - browse：7784

The biotech company Acelyrin, which raised more than $500 million in an IPO this year, ran into its first major setback Monday as its investigational anti-inflammatory drug missed the primary goal in a pivotal clinical trial.

Acelyrin’s medicine, a subcutaneous treatment called izokibep, is meant to clear up lesions for patients with the common skin disease hidradenitis suppurativa, or HS, an inflammatory disorder that leads to abscesses and scars. But after 16 weeks of treatment, patients who received izokibep did not show significant improvements compared to those taking a placebo, failing the study’s primary endpoint.

Acelyrin’s share price fell more than 60% in after-hours trading Monday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： How to fix cancer clinical trials' diversity problem

hotspot

Wikipedia

WSS

Wegovy leads to weight loss. Can it treat depression, too?

Ethical issues complicate the benefits of medical crowdfunding

Bernie Sanders is gearing up to subpoena pharma CEOs

Medicaid rebukes states for mistakenly disenrolling children

Readout Newsletter: The latest on Novavax, Merck, Bluebird

Wegovy leads to weight loss. Can it treat depression, too?

explore

hotspot

focus

After affirmative action ruling, medical educators look to 'holistic review'

Stem cell treatment guidelines are released by FDA

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Snackable artificial intelligence, expert AI, and the pharma industry

Guidelines to prevent youth baseball injuries need more muscle

Humana sues Biden admin over Medicare Advantage audit rule

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Zyn nicotine pouches become unlikely player in latest culture war

Wildfire smoke exposes gaps in outdoor worker protections

What American doctors can learn from their Israeli counterparts

knowledge

Weighted lottery helped low

Venture capital firm's plans to take over Akron hospital face hurdles

The 10 drugs up first for Medicare price negotiation

Humana sues Biden admin over Medicare Advantage audit rule

Philips to halt sales of sleep apnea machines in U.S.

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

hotspot

hotspot

Wikipedia

explore